Nationwide Fund Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-43,926
| Closed | -$230K | – | 238 |
|
|
2017
Q3 | $230K | Sell |
43,926
-2,223
| -5% | -$11.6K | ﹤0.01% | 2571 |
|
|
2017
Q2 | $257K | Buy |
46,149
+1,975
| +4% | +$11K | ﹤0.01% | 2523 |
|
|
2017
Q1 | $371K | Sell |
44,174
-1,739
| -4% | -$14.6K | ﹤0.01% | 2312 |
|
|
2016
Q4 | $291K | Sell |
45,913
-2,700
| -6% | -$17.1K | ﹤0.01% | 2444 |
|
|
2016
Q3 | $214K | Hold |
48,613
| – | – | ﹤0.01% | 2591 |
|
|
2016
Q2 | $138K | Sell |
48,613
-35,856
| -42% | -$102K | ﹤0.01% | 2784 |
|
|
2016
Q1 | $238K | Sell |
84,469
-45,679
| -35% | -$129K | ﹤0.01% | 2453 |
|
|
2015
Q4 | $1.34M | Sell |
130,148
-105
| -0.1% | -$1.08K | 0.01% | 1567 |
|
|
2015
Q3 | $1.49M | Buy |
130,253
+51,317
| +65% | +$585K | 0.01% | 1526 |
|
|
2015
Q2 | $1.18M | Sell |
78,936
-10,524
| -12% | -$157K | ﹤0.01% | 1762 |
|
|
2015
Q1 | $808K | Buy |
89,460
+23,783
| +36% | +$215K | ﹤0.01% | 1996 |
|
|
2014
Q4 | $799K | Buy |
65,677
+11,878
| +22% | +$145K | ﹤0.01% | 1924 |
|
|
2014
Q3 | $526K | Sell |
53,799
-206
| -0.4% | -$2.01K | ﹤0.01% | 2179 |
|
|
2014
Q2 | $689K | Buy |
+54,005
| New | +$689K | ﹤0.01% | 2079 |
|
|
2013
Q3 | – | Sell |
-22,090
| Closed | -$34K | – | 3262 |
|
|
2013
Q2 | $34K | Buy |
+22,090
| New | +$34K | ﹤0.01% | 3029 |
|